ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998

Three Fourths Of Pediatric Patients are Getting Best Treatment; NCI Goal: Reach all The Others

May 20, 1977

NCI Seeks to Maintain Grant Success Rate As Budget Deadlock Deepens on Capitol Hill

April 25, 2013